Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 3 8Phase NA 6Phase 2/3 5Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1Phase 4 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Quality of Life 1Breast Neoplasms 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Melatonin × Clear all
NCT07067307 2025-07-16

Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Mansoura University

Phase 1/2 Not yet recruiting
80 enrolled
Breast

Breast Neoplasms

NCT02486796 2018-08-01

Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer

Midwestern Regional Medical Center

Phase 1/2 Terminated
5 enrolled 8 charts

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon âš¡